Q&A With Gerald Smetana, MD, from Beth Israel Deaconess Medical Center: Weighing Benefits of Vorapaxar for Patients
With primary care physicians treating such a broad spectrum of conditions they also have a number of medications they can prescribe to help their patients. While some of these are more beneficial than others it is important to consider which might be more effective for patients.
With primary care physicians treating such a broad spectrum of conditions they also have a number of medications they can prescribe to help their patients. While some of these are more beneficial than others it is important to consider which might be more effective for patients.
Gerald Smetana, MD, from Beth Israel Deaconess Medical Center discussed four medications during the American College of Physicians Internal Medicine Meeting in Boston. One medication discussed, Vorapaxar, has been approved to help patients avoid a second cardiovascular event.
